ARTICLE | Company News
Dainippon Sumitomo, Takeda deal
June 29, 2015 7:00 AM UTC
The partners will terminate a 2011 deal granting Takeda exclusive rights to develop and commercialize Latuda lurasidone for schizophrenia and bipolar disorder in the EU, Switzerland, Norway, Turkey a...